Meclofenamate Sodium (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Meclofenamate Sodium drug offered from Mylan Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: meclofenamate sodium
SUBSTANCE NAME: MECLOFENAMATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1986-09-03
END MARKETING DATE: 0000-00-00


Meclofenamate Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMeclofenamate Sodium from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 1986-09-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-2150_939c7a2c-483f-4b5b-87a1-52e26fd4e469
PRODUCT NDC: 0378-2150
APPLICATION NUMBER: ANDA071081

Other MECLOFENAMATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Pharmaceuticals Inc.Meclofenamate Sodium